| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |